Movement Alert|Intel Rises 5.11% in Regular Trading, Rare x86 IP Licensing Coupled with Semiconductor Sector Recovery Extends Rebound

Market Focus
Jul 31

On July 31, Intel rose 5.11% in regular trading, trading at $97.73/share, with turnover of $981 million, extending the prior session's over 6% intraday gain and subsequent 3%+ after-hours advance.

On the news front, Intel has provided stealth startup RosaicLabs with access to portions of its Atom processor technology, including register-transfer level code, enabling custom chip design development based on Intel's x86 intellectual property. The move represents a rare external licensing of Intel's historically guarded x86 architecture, and is interpreted by the market as a positive signal for foundry ecosystem expansion. RosaicLabs is led by Amarjit Gill, a longtime co-investor of Intel CEO Lip-Bu Tan, and is pursuing a $10 million seed funding round.

At the sector level, the Philadelphia Semiconductor Index surged over 7% in the prior session, with Intel gaining over 11%, providing systemic uplift. Intel had previously declined over 10% cumulatively across multiple sessions. Combined with Q2 revenue of $16.1 billion representing 25% year-over-year growth and adjusted EPS of $0.42 doubling expectations, the current rebound reflects both event catalysis and technical recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10